Cases & Deals

Cellegy Pharmaceuticals defends against litigation involving unfair competition and other claims in licensing, development, and marketing of hormone replacement drug

Clients Cellegy Pharmaceuticals, Inc.

Jones Day represented Cellegy Pharmaceuticals, Inc. in an unfair competition, fraudulent inducement, and breach of contract action over the licensing, development, and marketing of a hormone replacement pharmaceutical under review by FDA.

PDI, Inc. v. Cellegy Pharmaceuticals, Inc., Case No. C 03-05602 SC (N.D. Cal., San Francisco Div.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.